{"id":71661,"date":"2026-10-15T15:38:39","date_gmt":"2026-10-15T15:38:39","guid":{"rendered":"https:\/\/alger16.dz\/?p=71661"},"modified":"2026-10-15T15:38:39","modified_gmt":"2026-10-15T15:38:39","slug":"industrie-pharmaceutique-signature-dun-accord-de-partenariat-entre-pharma-invest-et-le-chinois-yangtze-river-pharmaceutical","status":"publish","type":"post","link":"https:\/\/alger16.dz\/?p=71661","title":{"rendered":"Industrie pharmaceutique : Signature d&rsquo;un accord de partenariat entre Pharma Invest et le chinois Yangtze River Pharmaceutical"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"605\" src=\"https:\/\/alger16.dz\/wp-content\/uploads\/2026\/10\/12591-1024x605.jpg\" alt=\"\" class=\"wp-image-71662\" srcset=\"https:\/\/alger16.dz\/wp-content\/uploads\/2026\/10\/12591-1024x605.jpg 1024w, https:\/\/alger16.dz\/wp-content\/uploads\/2026\/10\/12591-300x177.jpg 300w, https:\/\/alger16.dz\/wp-content\/uploads\/2026\/10\/12591-767x453.jpg 767w, https:\/\/alger16.dz\/wp-content\/uploads\/2026\/10\/12591-1536x907.jpg 1536w, https:\/\/alger16.dz\/wp-content\/uploads\/2026\/10\/12591.jpg 1920w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">L&rsquo;entreprise Pharma Invest, sp\u00e9cialis\u00e9e dans la fabrication de m\u00e9dicaments, a sign\u00e9 un accord de partenariat et de coop\u00e9ration avec l&rsquo;op\u00e9rateur chinois Yangtze River Pharmaceutical Group (YRPG), en vue de renforcer la coop\u00e9ration entre les deux parties, indique jeudi un communiqu\u00e9 du minist\u00e8re de l&rsquo;Industrie pharmaceutique.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La c\u00e9r\u00e9monie de signature s&rsquo;est d\u00e9roul\u00e9e au si\u00e8ge du minist\u00e8re, sous la supervision du ministre de l&rsquo;Industrie pharmaceutique, Ouacim Kouidri, en pr\u00e9sence de cadres du minist\u00e8re et du Directeur g\u00e9n\u00e9ral du groupe public Saidal.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Cet accord vise \u00e0 renforcer la coop\u00e9ration entre les deux parties en mati\u00e8re de transfert d&rsquo;expertises et de technologies modernes pour la ma\u00eetrise de la production de mati\u00e8res premi\u00e8res \u00e0 usage pharmaceutique, ainsi qu&rsquo;\u00e0 accompagner Pharma Invest dans le d\u00e9veloppement et la fabrication de m\u00e9dicaments innovants, de mani\u00e8re \u00e0 renforcer les capacit\u00e9s technologiques et industrielles nationales et \u00e0 contribuer \u00e0 la promotion de la qualit\u00e9 de la production locale, selon le communiqu\u00e9.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Il a \u00e9t\u00e9 proc\u00e9d\u00e9, \u00e0 cette occasion, \u00e0 la mise au point des grandes lignes pour la conclusion prochaine d&rsquo;un accord regroupant Saidal et Pharma Invest en vue d&rsquo;une coop\u00e9ration dans la fabrication et la distribution de m\u00e9dicaments \u00e0 forte valeur ajout\u00e9e.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">M. Kouidri a salu\u00e9 de telles initiatives qui \u00ab\u00a0contribuent \u00e0 orienter l&rsquo;industrie pharmaceutique nationale vers la production de m\u00e9dicaments innovants et la ma\u00eetrise des technologies de pointe pour la fabrication de mati\u00e8res premi\u00e8res \u00e0 usage pharmaceutique, renfor\u00e7ant ainsi les capacit\u00e9s nationales en la mati\u00e8re et appuyant le processus de concr\u00e9tisation de la souverainet\u00e9 sanitaire\u00a0\u00bb, conclut le communiqu\u00e9.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>L&rsquo;entreprise Pharma Invest, sp\u00e9cialis\u00e9e dans la fabrication de m\u00e9dicaments, a sign\u00e9 un accord de partenariat et de coop\u00e9ration avec l&rsquo;op\u00e9rateur chinois Yangtze River Pharmaceutical Group (YRPG), en vue de renforcer la coop\u00e9ration entre les deux parties, indique jeudi un communiqu\u00e9 du minist\u00e8re de l&rsquo;Industrie pharmaceutique. La c\u00e9r\u00e9monie de signature s&rsquo;est [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":71662,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[63],"tags":[325,1428],"class_list":["post-71661","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-economie","tag-algerie-chine","tag-industrie-pharmaceutique"],"_links":{"self":[{"href":"https:\/\/alger16.dz\/index.php?rest_route=\/wp\/v2\/posts\/71661","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alger16.dz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alger16.dz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alger16.dz\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/alger16.dz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=71661"}],"version-history":[{"count":1,"href":"https:\/\/alger16.dz\/index.php?rest_route=\/wp\/v2\/posts\/71661\/revisions"}],"predecessor-version":[{"id":71663,"href":"https:\/\/alger16.dz\/index.php?rest_route=\/wp\/v2\/posts\/71661\/revisions\/71663"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alger16.dz\/index.php?rest_route=\/wp\/v2\/media\/71662"}],"wp:attachment":[{"href":"https:\/\/alger16.dz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=71661"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alger16.dz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=71661"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alger16.dz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=71661"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}